Interactions between paraoxonase 1 genetic polymorphisms and smoking and their effects on oxidative stress and lung cancer risk in a Korean population

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Eom, Sang Yong ^a,b   Yim, Dong Hyuk ^a,b   Lee, Chul Ho ^c   Choe, Kang Hyeon ^a   An, Jin Young ^a   Lee, Kye Young ^d   Kim, Yong Dae ^a,b   Kim, Heon ^a,b  

^a Chungbuk National University College of Medicine   (South Korea)

^b Chungbuk National University Hospital   (South Korea)

^c Korea Environment Corporation   (South Korea)

^d Konkuk University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ARYLDIALKYLPHOSPHATASE 1; THIOBARBITURIC ACID REACTIVE SUBSTANCE; ARYLDIALKYLPHOSPHATASE; PON1 PROTEIN, HUMAN;

AGED; ARTICLE; ASSAY; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; FEMALE; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; KOREAN (PEOPLE); LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; URINE LEVEL; COCARCINOGENESIS; GENETIC PREDISPOSITION; GENETICS; LUNG TUMOR; MIDDLE AGED; SOUTH KOREA;

NICOTIANA TABACUM;

AGED; ARYLDIALKYLPHOSPHATASE; COCARCINOGENESIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYMORPHISM, SINGLE NUCLEOTIDE; REPUBLIC OF KOREA; SMOKING;

EID: 84924311365     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119100     Document Type: Article

References (48)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917. doi:10.1002/ijc.25516 PMID: 21351269.
2. Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS (2013) Cancer statistics in korea: Incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 45: 1-14. doi:10.4143/crt.2013.45.1.1 PMID: 23613665.
3. Ahsan H, Thomas DC (2004) Lung cancer etiology: Independent and joint effects of genetics, tobacco, and arsenic. JAMA 292: 3026-3029. PMID: 15613673.
4. Alberg A, Brock M, Ford J, Samet J, Spivack S (2013) Epidemiology of lung cancer. Chest 143: e1S- e29S. doi:10.1378/chest.12-2345 PMID: 23649439.
5. In KH, Kwon YS, Oh IJ, Kim KS, Jung MH, Lee KH, et al. (2009) Lung cancer patients who are asymptomatic at diagnosis show favorable prognosis: A korean lung cancer registry study. Lung Cancer 64: 232-237. doi:10.1016/j.lungcan.2008.08.005PMID: 18809225.
6. Hecht SS (1999) Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91: 1194-1210. PMID: 10413421.
7. Valko M, Rhodes C, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160: 1-40. PMID: 16430879.
8. Halliwell B, Gutteridge JM, editors (2007) Free radicals in biology and medicine.: Oxford University Press.
9. Crawford A, Fassett RG, Geraghty DP, Kunde DA, Ball MJ, Robertson IK, et al. (2012) Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease. Gene 501: 89-103. doi:10.1016/j.gene.2012.04.011 PMID: 22525041.
10. Rozenberg O, Rosenblat M, Coleman R, Shih DM, Aviram M (2003) Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: Studies in PON1-knockout mice. Free Radic Biol Med 34: 774-784. PMID: 12633754.
11. Costa LG, Richter RJ, Li WF, Cole T, Guizzetti M, Furlong CE (2003) Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity. Biomarkers 8: 1-12. PMID: 12519632.
12. Costa LG, Vitalone A, Cole TB, Furlong CE (2005) Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 69: 541-550. PMID: 15670573.
13. Bhattacharyya T, Nicholls SJ, Topol EJ, Zhang R, Yang X, Schmitt D, et al. (2008) Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA 299: 1265-1276. doi:10.1001/jama.299.11.1265 PMID: 18349088.
14. Mackness B, Beltran-Debon R, Aragones G, Joven J, Camps J, Mackness M (2010) Human tissue distribution of paraoxonases 1 and 2 mRNA. IUBMB Life 62: 480-482. doi:10.1002/iub.347 PMID: 20503442.
15. Rodrigo L, Hernandez AF, Lopez-Caballero JJ, Gil F, Pla A (2001) Immunohistochemical evidence for the expression and induction of paraoxonase in rat liver, kidney, lung and brain tissue. implications for its physiological role. Chem Biol Interact 137: 123-137. PMID: 11551529.
16. Rainwater DL, Rutherford S, Dyer TD, Rainwater ED, Cole SA, Vandeberg JL, et al. (2009) Determinants of variation in human serum paraoxonase activity. Heredity (Edinb) 102: 147-154. doi:10.1038/hdy.2008.110PMID: 18971955.
17. Eom SY, Kim YS, Lee CJ, Lee CH, Kim YD, Kim H (2011) Effects of intronic and exonic polymorphisms of paraoxonase 1 (PON1) gene on serum PON1 activity in a korean population. J Korean Med Sci 26: 720-725. doi:10.3346/jkms.2011.26.6.720 PMID: 21655055.
18. Fang DH, Fan CH, Ji Q, Qi BX, Li J, Wang L (2012) Differential effects of paraoxonase 1 (PON1) polymorphisms on cancer risk: Evidence from 25 published studies. Mol Biol Rep 39: 6801-6809. doi:10.1007/s11033-012-1505-3 PMID: 22322559.
19. Lee CH, Lee KY, Choe KH, Hong YC, Kim YD, Kang JW, et al. (2005) Effects of oxidative DNA damage induced by polycyclic aromatic hydrocarbons and genetic polymorphism of the paraoxonase-1 (PON1) gene on lung cancer. J Prev Med Public Health 38: 345-350. PMID: 16323636.
20. Aksoy-Sagirli P, Cakmakoglu B, Isbir T, Kaytan-Saglam E, Kizir A, Topuz E, et al. (2011) Paraoxonase- 1 192/55 polymorphisms and the risk of lung cancer in a turkish population. Anticancer Res 31: 2225- 2229. PMID: 21737645.
21. Wang H, Li L, Ding L, Zhang Z, Pu C (2012) Association of genetic polymorphisms in the paraoxonase 1 gene with the risk and prognosis of non-small cell lung cancer in chinese han population. J Investig Med 60: 592-597. doi:10.231/JIM.0b013e318245d557 PMID: 22367101.
22. Harik-Khan RI, Wise RA, Fozard JL (1998) Determinants of maximal inspiratory pressure. the baltimore longitudinal study of aging. Am J Respir Crit Care Med 158: 1459-1464. PMID: 9817693.
23. Kang HJ, Choi KO, Kim BD, Kim S, Kim YJ (2005) FESD: A functional element SNPs database in human. Nucleic Acids Res 33: D518-22. PMID: 15608252.
24. Agarwal R, Chase SD (2002) Rapid, fluorimetric-liquid chromatographic determination of malondialdehyde in biological samples. J Chromatogr B Analyt Technol Biomed Life Sci 775: 121-126. PMID: 12101069.
25. Purcell S, Cherny SS, Sham PC (2003) Genetic power calculator: Design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19: 149-150. PMID: 12499305.
26. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol: 289-300.
27. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haplo view: Analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265. PMID: 15297300.
28. Sole X, Guino E, Valls J, Iniesta R, Moreno V (2006) SNP Stats: A web tool for the analysis of association studies. Bioinformatics 22: 1928-1929. PMID: 16720584.
29. Seo T, Pahwa P, McDuffie HH, Nakada N, Goto S, Ghosh S, et al. (2008) Interactive effect of paraoxonase- 1 Q192R polymorphism and smoking history on the lung function decline in grain workers. Ann Epidemiol 18: 330-334. PMID: 18083534.
30. Ozturk O, Kagnici OF, Ozturk T, Durak H, Tuzuner BM, Kisakesen HI, et al. (2009) 192R allele of paraoxanase 1 (PON1) gene as a new marker for susceptibility to bladder cancer. Anticancer Res 29: 4041-4046. PMID: 19846948.
31. Lurie G, Wilkens LR, Thompson PJ, McDuffie KE, Carney ME, Terada KY, et al. (2008) Genetic polymorphisms in the paraoxonase 1 gene and risk of ovarian epithelial carcinoma. Cancer Epidemiol Biomarkers Prev 17: 2070-2077. doi:10.1158/1055-9965.EPI-08-0145PMID: 18708400.
32. Conesa-Zamora P, Ruiz-Cosano J, Torres-Moreno D, Español I, Gutiérrez-Meca MD, Trujillo-Santos J, et al. (2013) Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: A case control study. BMC Cancer 13: 228. doi:10.1186/1471-2407-13-228 PMID: 23651475.
33. Saadat M (2012) Paraoxonase 1 genetic polymorphisms and susceptibility to breast cancer: A metaanalysis. Cancer epidemiol 36: e101-e103. doi:10.1016/j.canep.2011.10.015 PMID: 22133529.
34. Antognelli C, Mearini L, Talesa VN, Giannantoni A, Mearini E (2005) Association of CYP17, GSTP1, and PON1 polymorphisms with the risk of prostate cancer. Prostate 63: 240-251. PMID: 15538743.
35. Nishio E, Watanabe Y (1997) Cigarette smoke extract inhibits plasma paraoxonase activity by modification of the enzyme's free thiols. Biochem Biophys Res Commun 236: 289-293. PMID: 9240427.
36. Huang Y, Wu Z, Riwanto M, Gao S, Levison BS, Gu X, et al. (2013) Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex. J Clin Invest 123: 3815-3828. doi:10.1172/JCI67478 PMID: 23908111.
37. Parry H, Cohen S, Schlarb JE, Tyrrell DA, Fisher A, Russell MA, et al. (1997) Smoking, alcohol consumption, and leukocyte counts. Am J Clin Pathol 107: 64-67. PMID: 8980369.
38. Loke WM, Lam KM, Chong WL, Chew SE, Quek AM, Lim ECh, et al. (2012) Products of 5-lipoxygenase and my eloper oxidase activities are increased in young male cigarette smokers. Free Radic Res 46: 1230-1237. doi:10.3109/10715762.2012.701291 PMID: 22690830.
39. Zengi O, Karakas A, Ergun U, Senes M, Inan L, Yucel D (2012) Urinary 8-hydroxy-20-deoxyguanosine level and plasma paraoxonase 1 activity with alzheimer's disease. Clin Chem Lab Med 50: 529-534. doi:10.1515/CCLM.2011.792 PMID: 22098435.
40. Karaman E, Uzun H, Papila I, Balci H, Ozdilek A, Genc H, et al. (2010) Serum paraoxonase activity and oxidative DNA damage in patients with laryngeal squamous cell carcinoma. J Craniofac Surg 21: 1745-1749. doi:10.1097/SCS.0b013e3181f4040a PMID: 21119413.
41. Ji G, Gu A, Wang Y, Huang C, Hu F, Zhou Y, et al. (2012) Genetic variants in antioxidant genes are associated with sperm DNA damage and risk of male infertility in a chinese population. Free Radic Biol Med 52: 775-780. doi:10.1016/j.freeradbiomed.2011.11.032 PMID: 22206979.
42. Min J, Park H, Park B, Kim YJ, Park J, Lee H, et al. (2006) Paraoxonase gene polymorphism and vitamin levels during pregnancy: Relationship with maternal oxidative stress and neonatal birth weights. Reprod Toxicol 22: 418-424. PMID: 16515855.
43. Costa LG, Richter RJ, Li WF, Cole T, Guizzetti M, Furlong CE (2003) Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity. Biomarkers 8: 1-12. PMID: 12519632.
44. Mackness B, Mackness MI, Arrol S, Turkie W, Durrington PN (1998) Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett 423: 57-60. PMID: 9506841.
45. Aydin O, Yacinkaya S, Eren E, Ergin M, Eroglu M, Yilmaz N (2013) Diminished arylesterase enzyme activity and total thiol levels in bladder cancer patients. Clin Lab 59:1231-1237. PMID: 24409656.
46. Kurtul N, Söylemez S, Çelik M (2014) Plasma paraoxonase and arylesterase activities in smokers and smokeless tobacco users as maras powder. Inhal Toxicol 26: 235-239. doi:10.3109/08958378.2013.878007 PMID: 24568579.
47. Gaidukov L, RosenblatM, Aviram M, Tawfik DS (2006) The 192R/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, lipolactonase stimulation, and cholesterol efflux. J Lipid Res 47: 2492-2502. PMID: 16914770.
48. Elkiran ET, Mar N, Aygen B, Gursu F, Karaoglu A, Koca S (2007) Serum paraoxonase and arylesterase activities in patients with lung cancer in a turkish population. BMC Cancer 7: 48. PMID: 17362500.